Connor Iapoce

Wearing glasses was inversely associated with COVID-19 in an unadjusted analysis, but the association did not remain when adjusting for confounders.

Regardless of frailty status, edoxaban 15 mg was associated with significantly reduced incidence of the study outcomes compared with placebo.

Vaccine-associated myocarditis was largely restricted to men younger than 40 years, according to the new findings.

Real time CGM was significantly greater time in range, lower time below range, and lower glycemic variability compared to intermittently scanned CGM.

Data suggest eyes with a higher ratio of drops taken versus prescribed were significantly more likely to achieve target IOP at 6 months or 1 year.

No advantage was associated with blue light-filtering IOLs in terms of risk of all-cause or traffic-related injury and comfort with driving.

Data suggest most patients who receive a new diagnosis of PACG in the United States do not have a prior diagnosis of anatomical narrow angle.

The scientific statement reviews symptoms associated with ACS, heart failure, valvular disorders, stroke, rhythm disorders, and peripheral vascular disease.

Significant rapid improvement were observed in both signs and symptoms of thyroid eye disease at week 6 after 2 infusions of 10mg/kg VRDN-001.

Ultra-widefield fluorescein angiography allow more accurate risk identification of eyes with non proliferative diabetic retinopathy than baseline severity level alone in new findings.

An increasing retinal nonperfusion index was associated with a significantly higher risk of Diabetic Retinopathy Severity Scale worsening.

Glargine and detemir insulin were modestly associated with a reduced risk of MACE compared to neutral protamine Hagedorn insulin.

Participants in the least deprived group had one quarter the odds of no change/increase in mean HbA1c compared with the most deprived group.

A conversation on advancements in diabetes, the rising cost of insulin, and advice regarding disease management.

26 weeks of treatment with empagliflozin reduced the myocardial glucose metabolic rate by 45.1% in patients with type 2 diabetes.

A total of 178 patients achieved inactive disease while continuing adalimumab, and 51 patients maintained remission after discontinuing adalimumab.

A smaller decrease in VA at 4 months was observed in the guideline adherent groups when compared with the non-adherent groups.

New data on the incidence of glaucoma among rural subjects ≥40 years old in China report a 0.4% annual rate.

The findings suggest access to the vaccine was lowest among those who reported blindness, deafness, or multiple disabilities.

Topical OCS-01 was significantly more effective than vehicle in improving central macular thickness in patients with DME, according to new phase 2 data.

Functional and anatomical improvements with aflibercept treatment were obtained at week 24 and persisted until week 52.

Intravitreal 0.2 or 0.1 mg ranibizumab induced a faster regression of plus disease, stage 3 ROP, and AP-ROP compared to laser.

Daily self-imaging scans and in-office OCT scans graded by human experts agreed on the fluid status in 96% of the cases.

Data show foveal thickness fluctuation was significantly associated with logMAR BCVA and the defect length of the foveal EZ band.

Both a higher self-reported water intake and a greater measured 24-h urine volume were tied to an increased DED prevalence.

The screening of more than 50,000 youth patients in diverse populations of Colorado and Bavaria, Germany reported no association between infection and T1D.

Early time-restricted eating was more effective for losing weight than eating over a window of ≥12 hours, but did not affect body fat.

However, 82% of patients with proliferative diabetic retinopathy at year 2 of the RECOVERY trial demonstrated an improvement in DRSS levels from baseline.

All 6 screening strategies using wrist-worn wearable devices were estimated to be more effective than no screening.

The combined exposure to lower CETP and PCSK9 concentrations was associated with an additive magnitude with lipids and all outcomes.